Dr. James Kublin is the Executive Director of the HIV Vaccine Trials Network based at Fred Hutchinson Cancer Research Center. He is also the Medical Director of the Malaria Clinical Trials Center at Seattle BioMed, and a faculty member in the Department of Global Health at the University of Washington.
He has conducted extensive research on HIV and malaria in South America, SE Asia, and Africa, including clinical trials of novel therapies and vaccines.
Before moving to Seattle, Jim was Director, HIV Vaccines – Infectious Diseases, for Merck & Co., Inc., where he played a key role in the development and implementation of HIV vaccine studies, overseeing the coordination of clinical assays, site identification and development, government and ethical approvals and providing guidance on vaccine policy issues.
Jim completed his B.S. and M.D. at Georgetown University, and received his M.P.H. and completed a residency in Preventive Medicine at Johns Hopkins University. Jim continued work in vaccine development and molecular epidemiology while attending the University of Maryland’s School of Medicine for his fellowship in Vaccinology at the Center for Vaccine Development.